--- title: "Pro-Rata Rights, Definition | MedTech Terms" description: "Right of an existing investor to maintain ownership percentage in future rounds. Plain-English Investment & Finance definition for MedTech teams, with examples" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pro-rata-rights#term", "name": "Pro-Rata Rights", "description": "Pro-rata rights allow an investor to participate in future financings up to the amount needed to maintain their existing ownership percentage. Often called 'preemptive rights' in legal documents.", "url": "https://medtechterms.com/terms/pro-rata-rights", "termCode": "pro-rata-rights", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/pro-rata-rights#article", "headline": "Pro-Rata Rights", "description": "Right of an existing investor to maintain ownership percentage in future rounds.", "url": "https://medtechterms.com/terms/pro-rata-rights", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/pro-rata-rights" }, "about": { "@id": "https://medtechterms.com/terms/pro-rata-rights#term" }, "articleSection": "Investment & Finance", "inLanguage": "en", "keywords": "Pro-Rata Rights, Investment & Finance, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "Cooley GO: pro-rata", "url": "https://www.cooleygo.com/", "publisher": { "@type": "Organization", "name": "Cooley GO" } }, { "@type": "CreativeWork", "name": "NVCA Model Documents", "url": "https://nvca.org/model-legal-documents/", "publisher": { "@type": "Organization", "name": "NVCA" } }, { "@type": "CreativeWork", "name": "Silicon Valley Bank - Healthcare Reports", "url": "https://www.svb.com/trends-insights/", "publisher": { "@type": "Organization", "name": "SVB" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/term-sheet#term", "name": "Term Sheet", "url": "https://medtechterms.com/terms/term-sheet" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Investment & Finance", "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance" }, { "@type": "ListItem", "position": 4, "name": "Pro-Rata Rights", "item": "https://medtechterms.com/terms/pro-rata-rights" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/pro-rata-rights#faq", "mainEntity": [ { "@type": "Question", "name": "Are pro-rata rights mandatory in MedTech investment rounds?", "acceptedAnswer": { "@type": "Answer", "text": "No, pro-rata rights are not legally mandated but are a common provision negotiated between investors and companies, especially in competitive funding environments." } }, { "@type": "Question", "name": "How do pro-rata rights affect a MedTech company's capital structure?", "acceptedAnswer": { "@type": "Answer", "text": "They allow existing investors to maintain their ownership percentage, which can influence the distribution of equity and control as the company raises more capital over time." } }, { "@type": "Question", "name": "Can pro-rata rights be waived?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, investors can choose to waive their pro-rata rights, either in specific funding rounds or as part of a broader agreement, which can simplify fundraising processes." } }, { "@type": "Question", "name": "What is the difference between pro-rata rights and anti-dilution provisions?", "acceptedAnswer": { "@type": "Answer", "text": "Pro-rata rights allow investors to maintain their ownership percentage by participating in new rounds, while anti-dilution provisions protect investors from the dilutive effects of down rounds, typically by adjusting their conversion price." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Investment & Finance](/terms?cat=Investment%20%26%20Finance) 6. / 7. Pro-Rata Rights [All terms](/terms) Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle) # Pro-Rata Rights Right of an existing investor to maintain ownership percentage in future rounds. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Pro-rata rights allow an investor to participate in future financings up to the amount needed to maintain their existing ownership percentage. Often called 'preemptive rights' in legal documents. What the regulation says While not directly addressed by major MedTech regulations like the FDA 21 CFR 820 ( [Quality System Regulation](/terms/qsr)) or the EU [MDR](/terms/mdr-reporting) (Medical Device Regulation), pro-rata rights can indirectly impact a company's financial stability and ability to fund ongoing compliance efforts, such as [post-market surveillance](/terms/post-market-surveillance) or quality system improvements. Regulatory bodies expect companies to maintain adequate resources to meet their obligations throughout the product lifecycle. ## What this means in practice Coveted in oversubscribed MedTech rounds, where insiders compete with new investors for allocation. Major funds insist on pro-rata; smaller checks may not get them. ## Examples - A MedTech startup raises a Series A round, and its seed investors exercise their pro-rata rights to invest more, ensuring they retain their 15% ownership. This influx of capital helps fund ongoing clinical trials and quality system upgrades. - During a Series B round, a major venture capital firm insists on pro-rata rights to protect its substantial investment in a promising medical device company, securing its ability to participate in future growth. This ensures continued funding for regulatory submissions and market expansion. - A small angel investor in a digital health company chooses not to exercise their pro-rata rights in a subsequent, larger funding round due to limited capital, leading to a reduction in their overall ownership percentage. The company still successfully raises capital for product development. Common pitfalls - • Misunderstanding pro-rata rights can lead to significant dilution for early investors if they are unable to participate in subsequent funding rounds. - • Failing to clearly define pro-rata rights in investment agreements can result in legal disputes and delays in securing future financing. - • Overlooking the operational impact of pro-rata participation can strain a company's administrative resources during fundraising. - • Assuming all investors will exercise their pro-rata rights can lead to miscalculations in fundraising targets and available equity. - • Not considering the long-term implications of granting broad pro-rata rights on future investor interest can be a mistake. ## Frequently asked questions Are pro-rata rights mandatory in MedTech investment rounds? No, pro-rata rights are not legally mandated but are a common provision negotiated between investors and companies, especially in competitive funding environments. How do pro-rata rights affect a MedTech company's capital structure? Can pro-rata rights be waived? What is the difference between pro-rata rights and anti-dilution provisions? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Investment & Finance Term Sheet Non-binding outline of the key economic and control terms of an investment. ](/terms/term-sheet) ### More in Investment & Finance · Same category [ Investment & Finance 409A Valuation An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options. ](/terms/409a-valuation)[ Investment & Finance Anti-Dilution Protection Adjustment that protects investors if the company raises a future round at a lower price. ](/terms/anti-dilution)[ Investment & Finance Bridge Round Interim financing between priced rounds, usually convertible. ](/terms/bridge-round)[ Investment & Finance Burn Rate Rate at which a company spends cash, typically expressed monthly. ](/terms/burn-rate) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 Cooley GO· 1 NVCA· 1 SVB· 1 1. [1 Cooley GO: pro-rata Verified Cooley GO · cooleygo.com ](https://www.cooleygo.com/) 2. [2 NVCA Model Documents Verified NVCA · nvca.org ](https://nvca.org/model-legal-documents/) 3. [3 Silicon Valley Bank - Healthcare Reports Verified SVB · svb.com ](https://www.svb.com/trends-insights/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Diligencing a MedTech cybersecurity posture? Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Investment & Finance Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=pro-rata-rights) Learn in 60 seconds Card Lesson Quiz Right of an existing investor to maintain ownership percentage in future rounds. - · Coveted in oversubscribed MedTech rounds, where insiders compete with new investors for allocation. - · Major funds insist on pro-rata; smaller checks may not get them. - · Often called 'preemptive rights' in legal documents. Remember this Watch out: Misunderstanding pro-rata rights can lead to significant dilution for early investors if they are unable to participate in subsequent funding rounds. Related terms - [Term Sheet ](/terms/term-sheet) You may also need Auto-suggested from Investment & Finance and shared keywords. - [Drag-Along and Tag-Along Rights ](/terms/drag-tag-along) - [Dilution ](/terms/dilution) - [Post-Money Valuation ](/terms/post-money-valuation) - [Royalty Financing ](/terms/royalty-financing) - [Strategic Investor ](/terms/strategic-investor) - [Earn-Out ](/terms/earn-out) [All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)